Wall Street Zen lowered shares of LB Pharmaceuticals (NASDAQ:LBRX – Free Report) from a hold rating to a sell rating in a report released on Saturday morning. Other equities research analysts have also issued research reports about the company. Roth Capital reaffirmed a “buy” rating and issued a $37.00 target price on shares of LB […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Several other analysts also recently issued reports on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of […]